ZeroStack Corp.
As of Oct 22, 2026, ZeroStack is in Stage 1, the basing phase, now in week 7 (since Sep 10, 2026). It closed at $3.36, 78.0% below its 52-week high and below its 200-day average, which is falling.
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is ZSTK early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ZSTK among Asset Management132nd of 140 by relative strength
All 140 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CYPH | Stage 2 · wk 7 | 99 | −17.5% |
| 2 | AMTD | Stage 2 · wk 1 | 99 | +4011.1% |
| 3 | MGLD | Stage 2 · wk 4 | 94 | +105.2% |
| 4 | AAMI | Stage 2 · wk 41 | 94 | +1.4% |
| 5 | ASST | Stage 2 · wk 7 | 92 | +0.1% |
| 6 | AMG | Stage 2 · wk 21 | 91 | +8.0% |
| 7 | WT | Stage 2 · wk 39 | 91 | −10.6% |
| 8 | VCTR | Stage 2 · wk 39 | 91 | +1.0% |
| …132 | ZSTK | Stage 1 · wk 7 | 11 | −14.3% |
ZeroStack: quick answers
What stage is ZeroStack in?
As of Oct 22, 2026, ZeroStack (ZSTK) is in Stage 1, the basing phase. It entered Stage 1 on Sep 10, 2026 and is in week 7. What the four stages mean
Is ZeroStack in an uptrend?
Not yet. ZeroStack is in Stage 1, a base that can come before an uptrend. It trades 36.4% below its 200-day average, which is falling.
How far is ZeroStack from its 52-week high?
ZeroStack closed at $3.36 on Oct 22, 2026, 78.0% below its 52-week high of $15.28. Its 52-week low is $1.35.
How has ZeroStack performed over the past year?
As of Oct 22, 2026, ZeroStack is down 80.5% over the past year and down 50.9% so far in 2026.
Which sector and industry is ZeroStack in?
ZeroStack is in the Asset Management industry, part of the Financials sector.
About this companyFinancials· Asset Management
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.